Employers are facing unprecedented challenges in managing the complexities of pharmaceutical benefits, particularly with emerging therapies like gene and cell treatments. These cutting-edge therapies offer hope and new possibilities for treating conditions previously deemed untreatable, but they also make benefits plans increasingly complicated to manage.
During this webinar you’ll learn how to best position your organization financially while ensuring that every member facing a complex healthcare journey has the resources and support they need.
Join us to explore:
- The impact of gene and cell treatments and how they will affect your organization
- The benefits and challenges associated with using value-based care for high-cost therapies
- Why comprehensive healthcare navigation is essential for members with complex conditions
Panelists
Quantum Health
Quantum Health
Quantum Health
More like this
From Action to Impact: Proving the ROI of Navigation
Employers and consultants are demanding more than top-line ROI — they want proof of how interventions change outcomes.
Learn more
Beyond Fertility: Supporting Women's Health at Every Stage
Women’s and family health needs are evolving, and employers must rethink benefits strategies to provide inclusive, comprehensive support. Join industry experts for a conversation on creating equitable benefits that go beyond fertility treatment to improve access, outcomes and cost efficiency.
Learn more
Managing GLP-1 Costs Without Compromising Outcomes
GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.
Learn more